Grants for February 2013

Federal Awards ($100,000 and above)

February Awards

Aguirre, Vincent, NIH, Melanocortin-4 Receptor-Dependent Regulation of Energy Balance After Gastric Bypass in Mice, $142,668; Brekken, Rolf, NIH, Axl as Target for Therapy of Pancreatic Cancer, $155,621; Burstein, Ezra, NIH, Control of NF-kB and Inflammation by COMMD Proteins, $311,243; Butovich, Igor, NIH, Biochemistry and Biophysics of Preocular Tear Film, $274,377; Chiang, Cheng-Ming, NIH, E2-Cellular Complexes in HPV Chromatin Transcription, $296,933. 

Farrar, John, NIH, Type 1 Interferon-Regulated T Helper Development, $318,755; Garcia, Christine, NIH, Pulmonary Fibrosis and Telomerase Dysfunction, $391,901; Greenberg, David, NIH, Gene Silencing Therapeutics for Chronic Infections in Cystic Fibrosis, $248,343; Hendrixson, David, NIH, Structural Components of Campylobacter Jejuni Polar Flagellar Motor, $193,610; Huang, Chou-Long, NIH, Regulation of Renal Calcium Transport, $293,964. 

Jain, Raksha, NIH, Hormonal Influences on Airway Disease, $128,250; Jiang, Youxing, NIH, Molecular Mechanisms of Caton Channel Selectivity, $260,442; Lavery, Lawrence, New York Univ. School of Med/NIH, Wound EMR to Decrease Limb Amputations in Persons with Diabetes, $216,859; Lin, Weichun, NIH, Patterning and Formation of Neuromuscular Junction, $313,031; Mammen, Pradeep, NIH, Cytoglobin: Stress-Responsive Hemoprotein Modulating Cardiomyocyte Survival, $357,750.

Nam, Young-Jae, NIH, Cardiac Repair by Reprogramming Fibroblasts into Cardiomyocytes, $128,583; Niederkorn, Jerry, NIH, Transplant and Tumor Rejection Processes Within the Eye, $397,500; Niederkorn, Jerry, NIH, Immunological Modulation of Ocular Tumor Metastases, $141,085; Norgard, Michael, NIH, Structure and Function of Treponema Pallidum Lipoproteins, $346,221. 

Orth, Kim, NIH, Analysis of Orchestrated Cell Death Mediated by Vibrio Parahaemolytics T3SS1, $354,173; Pearson, Gray, NIH, Investigating Breast Cancer Collective Invasion, $148,466; Raskin, Philip, George Washington Univ./NIH, Glycemia Reduction Approaches for Diabetes: Comparative Effectiveness (GRADE), $244,316; Rogers, Zora, NIH, Baby HUG Follow-Up Study II, $174,856.

Thomas, Philip, NIH, Development of Membrane Protein Structure, $387,216; Xie, Yang, NIH, Predicting Adjuvant Chemotherapy Response in Lung Cancer, $151,221; Yarovinsky, Felix, NIH, Cellular and Molecular Mechanisms of Host Resistance to Toxoplasma Gondii, $354,173; Yu, Gang, NIH, Gamma-Secretase and Myelin: Paradigm Shift in Brain Disorders, $347,813; Zhu, Hao, NIH, Metabolic Roles for Lin28-let-7 MiRNA Pathway in Sarcoma Tumorigenesis, $140,000.

Non-Federal Awards ($50,000 and above)

Cannon, Carolyn, Cystic Fibrosis Fndtn., Therapeutics Development Center, $82,314; German, Dwight, Simons Fndtn., Identification of Candidate Serum Antibody Biomarkers for Autism Spectrum Disorders (ASD), $112,032; Hsieh, Jer-Tsong, UT Dallas/CPRIT, Development of Small Molecular Mimicking Pro-Apoptotic Proteins for Treating Prostate Cancer, $121,118.

Konopka, Genevieve, March of Dimes Fndtn., Characterization of Role of FOXP1 in Developing Brain and Autism-Related Signaling and Behaviors, $75,000; Lu, Richard (L. Wu, Fellow), Natl. Multiple Sclerosis Society, Functional Study of Transcriptional Regulator Sip1 in CNS Myelination and Remyelination, $51,642; Munshi, Nikhil, March of Dimes Fndtn., PouC is a Novel Regulator of AVC Morphogenesis, $75,000.

Parada, Luis, Neurofibromatosis Therapeutic Acceleration Program, Primary Plexiform Neurofibroma Cell Culture Model for Use in Cell-Based High-Throughput Screens, $165,000; Parks, Elizabeth, American Diabetes Assn., Insulin Resistance in Control of Intestinal Lipid Metabolism, $179,128; Pruitt, Sandi, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $270,457; White, Charles, Michael J. Fox Fndtn. for Parkinson’s Research, Characterization of MJFF Alpha-Synuclein Filament-Specific Antibodies, $64,101. 

Willson, James, American Cancer Society, Institutional Research Grant, $210,000; Word, Ann, March of Dimes Fndtn., Fetal Fibronectin, Target of Therapy for Premature Rupture of Fetal Membranes, $112,500; Yan, Nan, Alliance for Lupus Research, Identification of Endogenous Nucleic Acids as Targets in Lupus, $179,107.

Share: